These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7758479)

  • 1. Clinical and bacteriological features of relapsing shunt-associated meningitis due to Acinetobacter baumannii.
    Seifert H; Richter W; Pulverer G
    Eur J Clin Microbiol Infect Dis; 1995 Feb; 14(2):130-4. PubMed ID: 7758479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appearance of resistance to meropenem during the treatment of a patient with meningitis by Acinetobacter.
    Núñez ML; Martínez-Toldos MC; Bru M; Simarro E; Segovia M; Ruiz J
    Scand J Infect Dis; 1998; 30(4):421-3. PubMed ID: 9817528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postsurgical meningitis caused by Acinetobacter baumannii associated with high mortality.
    Huttova M; Freybergh PF; Rudinsky B; Sramka M; Kisac P; Bauer F; Ondrusova A
    Neuro Endocrinol Lett; 2007 Jun; 28 Suppl 2():15-6. PubMed ID: 17558367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tigecycline salvage therapy for ventriculoperitoneal shunt meningitis due to extensively drug-resistant Acinetobacter baumannii.
    Polat M; Ozkaya-Parlakay A
    Eur J Pediatr; 2019 Jan; 178(1):117-118. PubMed ID: 30353221
    [No Abstract]   [Full Text] [Related]  

  • 5. Acinetobacter species meningitis in children: a case series from Karachi, Pakistan.
    Saleem AF; Shah MS; Shaikh AS; Mir F; Zaidi AK
    J Infect Dev Ctries; 2011 Nov; 5(11):809-14. PubMed ID: 22112736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of ventriculoperitoneal shunt infection and ventriculitis caused by Acinetobacter baumannii: a case report.
    Demoz GT; Alebachew M; Legesse Y; Ayalneh B
    J Med Case Rep; 2018 May; 12(1):141. PubMed ID: 29788980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal meningitis with the presence of Acinetobacter spp.
    Gospodarek E; Kraśnicki K; Ziółkowski G; Kasprzak H; Beuth W
    Med Sci Monit; 2000; 6(1):50-4. PubMed ID: 11208283
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Soudeiha MAH; Dahdouh EA; Azar E; Sarkis DK; Daoud Z
    Front Cell Infect Microbiol; 2017; 7():209. PubMed ID: 28596943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cluster of nosocomial cross-infection due to multiple antibiotic-resistant Acinetobacter baumannii: Characterization of the strain and antibiotic susceptibility studies.
    Traub WH; Geipel U; Schwarze I; Bauer D
    Chemotherapy; 1999; 45(5):349-59. PubMed ID: 10473923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nosocomial postneurosurgical Acinetobacter baumannii meningitis: a retrospective study of six cases admitted to Hamad General Hospital, Qatar.
    Khan FY; Abukhattab M; Baager K
    J Hosp Infect; 2012 Feb; 80(2):176-9. PubMed ID: 22153953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acinetobacter, an infrequent cause of community acquired bacterial meningitis.
    Reindersma P; Nohlmans L; Korten JJ
    Clin Neurol Neurosurg; 1993 Mar; 95(1):71-3. PubMed ID: 8453820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Imipenem-cilastatin cure of meningitis caused by Acinetobacter calcoaceticus].
    Sánchez JF; Sanz-Hospital J; Guerrero A; Martínez-Beltrán J; Quereda C
    Enferm Infecc Microbiol Clin; 1991 Oct; 9(8):512-3. PubMed ID: 1805958
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of nosocomial meningitis due to a multidrug resistant Acinetobacter baumannii with intraventricular colistin.
    Bukhary Z; Mahmood W; Al-Khani A; Al-Abdely HM
    Saudi Med J; 2005 Apr; 26(4):656-8. PubMed ID: 15900379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic model for tobramycin in acinetobacter meningitis.
    Chicano-Piá PV; Cercós-Lletí AC; Romá-Sánchez E
    Ann Pharmacother; 2002 Jan; 36(1):83-6. PubMed ID: 11816266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of colistin-resistant Acinetobacter baumannii isolates in postneurosurgical meningitis in an intensive care unit with high presence of heteroresistance to colistin.
    Rodriguez CH; Bombicino K; Granados G; Nastro M; Vay C; Famiglietti A
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):188-91. PubMed ID: 19748431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nosocomial Acinetobacter meningitis.
    Kralinsky K; Krcmeryova T; Tuharsky J; Krcmery V
    Pediatr Infect Dis J; 2000 Mar; 19(3):270-1. PubMed ID: 10749482
    [No Abstract]   [Full Text] [Related]  

  • 17. Amikacin and colistin for treatment of Acinetobacter baumannii meningitis.
    Fulnecky EJ; Wright D; Scheld WM; Kanawati L; Shoham S
    J Infect; 2005 Dec; 51(5):e249-51. PubMed ID: 15913780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of meningitis caused by multidrug-resistant Acinetobacter baumannii with intravenous and intrathecal colistin.
    Ho YH; Wang LS; Chao HJ; Chang KC; Su CF
    J Microbiol Immunol Infect; 2007 Dec; 40(6):537-40. PubMed ID: 18087636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemiology of infections caused by Acinetobacter baumannii].
    Marcos MA; Vila J; Jiménez de Anta MT
    Enferm Infecc Microbiol Clin; 1993 Oct; 11(8):450-4. PubMed ID: 8260518
    [No Abstract]   [Full Text] [Related]  

  • 20. Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis.
    Jiménez-Mejías ME; Pichardo-Guerrero C; Márquez-Rivas FJ; Martín-Lozano D; Prados T; Pachón J
    Eur J Clin Microbiol Infect Dis; 2002 Mar; 21(3):212-4. PubMed ID: 11957024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.